Canadian Expert discussion on the treatment and management considerations for MIBC treatment regimens
Canadian Expert discussion on the treatment and management considerations for
MIBC treatment regimens
Featuring: Aly-Khan Lalani & Peter Black
By participating in this program, participants can expect to:
- Summarize key updates in the new CUA guidelines for MIBC and how they impact clinical decision-making in Canada
- Reflect on the latest advancements in perioperative treatments for patients with MIBC (NIAGARA and CM-274) and their potential implications for treatment strategies.
- Discuss treatment and management considerations for MIBC treatment regimens in the Canadian context, considering guideline updates, patient selection, and access to therapies.
ACCREDITATION
This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the Canadian Urological Association. You may claim a maximum of .5 hour of credit.
This program has received financial support from AstraZeneca Canada.